The design and solid-phase synthesis of tetrahydropyridazine-3,6-dione (Tpd) peptidomimetics derived from backbone-aminated peptides is reported. The described protocol features the synthesis of chiral α-hydrazino acids suitable for chemoselective incorporation into growing peptide chains. Acid-catalyzed cyclization to form the Tpd ring during cleavage affords the target peptidomimetics in good yield and purity. The scope of Tpd incorporation is demonstrated through the synthesis of constrained peptides featuring nucleophilic/electrophilic side chains and sterically encumbered α-substituted hydrazino acid residues.
The design and solid-phase synthesis of tetrahydropyridazine-3,6-dione (Tpd) peptidomimetics derived from backbone-aminated peptides is reported. The described protocol features the synthesis of chiral α-hydrazino acids suitable for chemoselective incorporation into growing peptide chains. Acid-catalyzed cyclization to form the Tpd ring during cleavage affords the target peptidomimetics in good yield and purity. The scope of Tpd incorporation is demonstrated through the synthesis of constrained peptides featuring nucleophilic/electrophilic side chains and sterically encumbered α-substituted hydrazino acid residues.
Peptide backbone tethering strategies
have proven useful for the elucidation of potential bioactive conformations
and for enhancing peptide stability. The Freidinger–Veber lactam[1] and related structures[1c,2] represent
important examples of cyclic constraints suitable for conformational
scanning of linear peptides. These motifs often retain the native
composition of the peptide backbone while restricting rotation about
the ω and ψ bonds across a dipeptide subunit. Given the
resurgence of peptides as lead structures for chemical probe and drug
discovery, there remains a need for new constraints to interrogate
local conformation. The ability to readily incorporate covalent tethers
using solid-phase peptide synthesis (SPPS) techniques will greatly
enhance their utility in structure–activity relationship studies.In an effort toward synthetically accessible rigidified peptides,
we targeted a tetrahydropyridazine-3,6-dione (Tpd) scaffold derived
from an N-aminated aspartyl dipeptide precursor (Figure 1).[3] The peptide backbone
amino substituent would provide not only a nucleophilic handle for
intramolecular cyclization but also an additional site for derivitization
or potential hydrogen-bonding interactions. Engaging the pro-R Cα substituent as the complementary tethering site
affords a Tpd constraint favoring the ψ torsion typical of a
β-strand, whereas tethering via the pro-S site
would favor a −120° ψ dihedral angle reminiscent
of a type II′ β-turn. Thus, changing the stereochemistry
of the presumed aspartate precursor could provide access to distinct
conformational probes.
Figure 1
Design of Tpd-constrained peptides.
Design of Tpd-constrained peptides.In contrast to peptoid (N-alkyl glycine
oligomer)
synthesis, the assembly of peptides bearing substituents on both Nα
and Cα remains a considerable challenge. The synthesis of peptide
tertiary amide (PTA) libraries on solid support was recently reported
based on a submonomer approach.[4] The on-resin
syntheses of some backbone aminated peptides have also been described,
though these have so far been limited to N-amino
glycine-containing structures (“azapeptoids”)[5] or to natural products harboring piperazic acid
derivatives.[6] To the best of our knowledge,
there exists no general methodology for preparing Cα-substituted N-amino peptide derivatives by conventional SPPS.To assess the feasibility of hydrazino acid acylation, we first
screened a variety of coupling reagents for the reaction between the
known esters 1(7) and Fmoc-protected
aspartate derivatives in solution (Scheme 1). Even with the less hindered N-amino glycine ester 1a, most common condensation reagents failed to effectively
promote dipeptide formation (entries 1–3 and 6–8). The
use of HATU gave moderate yields of 2a but afforded none
of the desired product when N-amino alanine derivative 1b was employed as the substrate (entries 4 and 5). Preactivation
of Fmoc-d-Asp(tBu)-OH or Fmoc-d-Asp(Me)-OH as the mixed anhydride[5c] gave
good yields of 2a–d; however, lower
conversions were again observed with the α-substituted coupling
partner 1b (entries 9–12). Yields improved with
in situ generation of the Fmoc-protected amino acid chloride using
triphosphgene. Optimal yields (>80%) and cleaner reactions were
obtained
when the acid chloride was preformed in the presence of thionyl chloride
and isolated prior to condensation (entries 15 and 16).[8] We found Fmoc-Asp(Me)-Cl to be a remarkably shelf-stable
solid that showed no appreciable erosion of enantiopurity during short-term
storage or coupling at elevated temperatures.[9] Formation of the tetrahydropyridazinedione ring was achieved in
moderate yield using DIC/DIEA/DMAP following Boc and tert-butyl ester deprotection of 2a. Alternatively, ring
closure was effected via acidolysis of 2c and subsequent
heating in toluene to give 3 in 53% yield.
Scheme 1
Solution
Phase Synthesis of Tpd Dipeptide Mimics
All reactions carried out at
rt for 24 h with 2–3 equiv of carboxylic acid and coupling
reagent, and excess base. Thionyl chloride
was used to generate Fmoc-(d)Asp(Me)-Cl. The isolated acid
chloride was reacted with the hydrazo ester derivatives in the presence
of collidine.
Solution
Phase Synthesis of Tpd Dipeptide Mimics
All reactions carried out at
rt for 24 h with 2–3 equiv of carboxylic acid and coupling
reagent, and excess base. Thionyl chloride
was used to generate Fmoc-(d)Asp(Me)-Cl. The isolated acid
chloride was reacted with the hydrazo ester derivatives in the presence
of collidine.We next explored a submonomer
approach to prepare a model peptidomimetic
containing a Tpd-Gly subunit on solid support. Analogous to well-established
methods for peptoid synthesis,[10] we employed
α-bromoacetic acid as a building block and carried out subsequent
SN2 displacement with tert-butyl carbazate
(Scheme 2). Condensation with 3 equiv of Fmoc-d-Asp(Me)-Cl in the presence of 9 equiv of collidine (50 °C,
1 h × 3) was followed by standard peptide elongation and cleavage
from the resin with 95:5 TFA/H2O. Under these conditions,
acidolysis was attended by Tpd ring closure to give peptidomimetic 5 as the major product in 23% overall yield after RP-HPLC
purification.
Scheme 2
SPPS of Tpd-Gly Peptidomimetics
In the course of extending the submonomer approach
to Cα-substituted
(nonglycine) variants, we observed the formation of diastereomeric
mixtures of Tpd peptidomimetics following cleavage. After ruling out
potential racemization of the d-Asp chiral center, we confirmed
the configurational instability of the intermediate chiral α-bromoacetamide
under the conditions required for efficient SN2 displacement
(Scheme 3). Reaction of 6a with
2 M tert-butyl carbazate in DMF at 50 °C followed
by acidic cleavage from the resin afforded a 1.2:1 diastereomeric
mixture of products (7), as judged by LCMS (acetone was
added to the cleavage cocktail to provide more well-resolved hydrazone
derivatives). The limitations of a bromoacetamide submonomer protocol
for Tpd synthesis were further highlighted in our attempt to prepare
the corresponding N-amino phenylalanine derivative
on solid support. Incubation of 6b with tert-butyl carbazate gave rise to cinnamide 8 as the major
product. Presumably, the competing elimination pathway would also
complicate the synthesis of other Tpd-Xaadipeptides capable of forming
extended conjugated systems (Xaa = Tyr, Trp, His, Asp/Asn).
Scheme 3
Attempted
Submonomer-Based SPPS of Cα,Nα-Disubstituted
Variants
To circumvent these
issues, we opted to incorporate Boc-protected
hydrazino acid building blocks into growing peptide chains. Chiral
α-hydroxy esters 9 were prepared by diazotization
of the corresponding d-amino acids[11] followed by esterification (Scheme 4). Installation
of the tert-butyl carbazate group via the triflate
and subsequent saponification gave acids 11a–f. Remarkably, solutions of 11 in 0.5 M aq. HCl
partitioned readily into ethyl acetate, suggesting that the α-amino
group is not easily protonated even at low pH. Previous failed acylation
attempts (see Scheme 2) confirmed the poor
nucleophilicity of thisnitrogen and prompted us to explore chemoselective
amidation at the C-terminus. Reaction of 11a with H-Phe-OMe
in the presence of HATU afforded the desired N-amino
dipeptide 12 in 84% yield without any detectable racemization
or self-condensation of the α-hydrazino acid.[12] Encouraged by this result, we reacted 5 equiv of 11a with resin-bound Tyr in the presence of 5 equiv of HATU,
and 10 equiv of DIEA in DMF at 50 °C to give intermediate 13. Elaboration of the model peptide and tandem cleavage/cyclization
as described above gave diastereomerically pure Tpd-containing tetrapeptide
mimic 14 in 27% overall yield following RP-HPLC purification.[13]
Scheme 4
Synthesis of Chiral α-Hydrazino Acids
and Cα-Substituted
Tpd Peptidomimetics
To demonstrate the broad utility of our solid-phase protocol,
we
carried out the synthesis of a variety of Tpd-containing peptidomimetics
as shown in Table 1. The described methodology
is tolerant of both d- and l-Tpd subunits, and the
six-membered ring closure is not adversely affected by the presence
of other electrophilic or nucleophilic side chains within the peptide.
In addition, hindered α-hydrazino acids such as N-amino-Ile, -Val, and -Leu can be readily incorporated. Analysis
of the crude HPLC traces for various Tpd peptidomimetics revealed
that the principle impurity is the trifluoroacetylated N-amino peptide. However, this byproduct is typically a minor component
of the crude mixture (<15%) and is readily removed during preparative
RP-HPLC purification. Only in the case of N-amino
serine-derivative 21 did we observe inefficient ring
closure. Although we were able to isolate the desired Tpd derivative
in low yield, LCMS revealed the major product to be the uncyclized N-amino peptide. The nucleophilicity of Nβ appeared
to be generally lower in this case, as the trifluoroacetylated byproduct
was also conspicuously absent from the crude mixture.
Table 1
Tpd Peptidomimetics Prepared by SPPS
In summary,
we have described the efficient synthesis of cyclic N-amino peptide derivatives for conformational scanning
of bioactive lead structures. Chiral α-hydrazino acid building
blocks were synthesized in solution and chemoselectively incorporated
on solid phase. Cleavage from the resin and concomitant ring closure
gave rise to rigidified peptidomimetics. Notably, our methodology
allows for the synthesis of Tpd-constrained peptides bearing various
native and sterically hindered side chains. Given that this protocol
is operationally simple and amenable to combinatorial synthesis, we
anticipate the Tpd motif will find broad application as a probe of
local peptide conformation. Efforts toward structurally defined and
biologically active N-amino peptide derivatives are
currently underway in our laboratory.
Authors: R E Dolle; C V Prasad; C P Prouty; J M Salvino; M M Awad; S J Schmidt; D Hoyer; T M Ross; T L Graybill; G J Speier; J Uhl; B E Miller; C T Helaszek; M A Ator Journal: J Med Chem Date: 1997-06-20 Impact factor: 7.446
Authors: Christopher J Hobbs; Rino A Bit; Andrew D Cansfield; Bill Harris; Christopher H Hill; Katherine L Hilyard; Ian R Kilford; Eric Kitas; Antonin Kroehn; Peter Lovell; David Pole; Paul Rugman; Brad S Sherborne; Ian E D Smith; David R Vesey; D Lee Walmsley; David Whittaker; Glyn Williams; Fiona Wilson; David Banner; Allan Surgenor; Neera Borkakoti Journal: Bioorg Med Chem Lett Date: 2002-05-20 Impact factor: 2.823
Authors: P D Williams; M G Bock; R D Tung; V M Garsky; D S Perlow; J M Erb; G F Lundell; N P Gould; W L Whitter; J B Hoffman Journal: J Med Chem Date: 1992-10-16 Impact factor: 7.446
Authors: Claudio Palomo; Jesus M Aizpurua; Ana Benito; José Ignacio Miranda; Raluca M Fratila; Carlos Matute; Maria Domercq; Federico Gago; Sonsoles Martin-Santamaria; Anthony Linden Journal: J Am Chem Soc Date: 2003-12-31 Impact factor: 15.419
Authors: Chang Won Kang; Matthew P Sarnowski; Sujeewa Ranatunga; Lukasz Wojtas; Rainer S Metcalf; Wayne C Guida; Juan R Del Valle Journal: Chem Commun (Camb) Date: 2015-11-21 Impact factor: 6.222
Authors: Kamlesh M Makwana; Matthew P Sarnowski; Jiayuan Miao; Yu-Shan Lin; Juan R Del Valle Journal: ACS Chem Neurosci Date: 2021-10-05 Impact factor: 5.780